Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/21/20 → 1/21/23 |
Funding
- Theradex (Prot #A19-11184 // Prot #A19-11184)
- Aprea Therapeutics AB (Prot #A19-11184 // Prot #A19-11184)
Prot #A19-11184: Phase I Study of APR-246 in Combination with Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies
- Altman, Jessica K (PD/PI)
Project: Research project